EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Exosomes in melanoma: Future potential for clinical theranostics

Asmit Das, Swarup Sonar, Rajib Dhar, Vetriselvan Subramaniyan

Pathology - Research and Practice · 2025

DOI: 10.1016/j.prp.2025.155950 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Asmit Das und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Maxillofacial Pathology, Neuron Institute of Applied Research, Amravati, Maharashtra, India. Hauptthemen laut MEDLINE: Exosomes, Melanoma, Skin Neoplasms, Theranostic Nanomedicine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 124 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma, an aggressive form of skin cancer, presents significant therapeutic challenges due to its resistance to conventional treatments and propensity for metastasis. Exosomes, nanoscale vesicles secreted by a wide variety of cells, have emerged as promising tools for developing novel melanoma therapies. Exosome-based therapeutic approaches offer several advantages, including inherent biocompatibility, low immunogenicity, and the ability to cross biological barriers. This review explores the therapeutic potential of exosomes in melanoma treatment, focusing on their multifaceted roles in modulating tumor cell behavior, enhancing anti-tumor immune responses, and serving as targeted drug delivery vehicles. We discuss various strategies employed to engineer exosomes for enhanced therapeutic efficacy, including loading them with chemotherapeutic agents, small interfering RNAs (siRNAs), microRNAs (miRNAs), and immunomodulatory molecules. Additionally, we highlight the potential of exosomes derived from diverse sources to enhance anti-cancer effects. Furthermore, we address the challenges and future directions in translating exosome-based therapies from bench to bedside, emphasizing the need for standardized isolation and manufacturing protocols, as well as rigorous preclinical and clinical evaluations to unlock the full therapeutic potential of exosomes in the fight against melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesMelanomaSkin NeoplasmsTheranostic NanomedicineHumansAnimalsDrug Delivery Systems

Stichwörter der Autor:innen

BiomarkersClinical trialMelanomaMetastasisTherapeutic

Autor:innen und Institutionen

  • Department of Oncology and Maxillofacial Pathology, Neuron Institute of Applied Research, Amravati, Maharashtra, India.
  • Department of Medical Sciences, School of Medical and Life Sciences, Sunway University, Bandar Sunway, Subang Jaya, Selangor 47500, Malaysia.
  • Department of Medical Sciences, School of Medical and Life Sciences, Sunway University, Bandar Sunway, Subang Jaya, Selangor 47500, Malaysia. Electronic address: vetris@sunway.edu.my.

Zitieren

APA

Das, A., Sonar, S., Dhar, R., & Subramaniyan, V. (2025). Exosomes in melanoma: Future potential for clinical theranostics. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.155950

Vancouver

Das A, Sonar S, Dhar R, Subramaniyan V. Exosomes in melanoma: Future potential for clinical theranostics. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.155950

BibTeX
@article{Das2025,
  author = {Das, Asmit and Sonar, Swarup and Dhar, Rajib and Subramaniyan, Vetriselvan},
  title = {Exosomes in melanoma: Future potential for clinical theranostics},
  journal = {Pathology - Research and Practice},
  year = {2025},
  doi = {10.1016/j.prp.2025.155950}
}
Kostenlos starten →